Exchange: NASDAQ·Updated 07:44 PM EST
RANI logo

RANI Rani Therapeutics Holdings Inc - Ordinary Shares Class A

$0.5202
$0.0695
(11.97%)
Today
Closed $0.5111
$0.0091
(1.78%)
After Hours
Reported EarningsNov 9
Mkt Cap$71.28M
Vol459,003.00

About RANI

Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.
79

Extremely Bullish Sentiment

How do you feel about RANI?

BBTAAPL
$RANI this is our time, with tech down people should be rotating into speculative biotech!
6
Mandalo
$RANI Interesting news, Rani Therapeutics brings this week! Q3 financial results and Nasdaq compliance updates, they have. Also, oral obesity pill data, we eagerly await. Much momentum in the capsule technology, there is. Hmmm.
5
Mandalo
$RANI Surged, Chugai's earnings have! Driven by strong exports and high royalties, it is. Up 14.1% to ¥1.07 trillion, nine-month revenue reached. Third-quarter net profit by 29.1% to ¥143 billion jumped, with a 50.1% operating margin, hmmm.
1
2
Mandalo
$RANI "Building strength on RANI, the Force is. Patience you must have, young investor—much risk there is, yet strong the upside could be."
4
ClaxtonGenZ
$RANI There's still so much to discover, and that's what makes following this interesting
4
wavw
$RANI $LLY 100k traded..whatever traded from 88 cents to 58 cents are very low volume. Can shoot up quickly. Easy BO target!!!
4
Carlisle007
$RANI rinse and repeat. This and $BIAF are my two faves on my portfolio that never disappoints me. +2 % or +3% gains 3x a week is not at all bad for flips 🥰🫶🏼
3
IBRwreXandeffex
$RANI is leading my undervalued under a dollar list. PT $8.50, currently waiting on Nov 9, 2026: Nasdaq deadline. The company has until November 9, 2026 to get back above the dollar minimum bid price. If it misses, it may get another 180 days by transferring to the Nasdaq Capital Market. That route requires stating an intent to do a reverse stock split if needed, so expect one. (Rani Therapeutics Holdings, Inc. - Form 8-K - FY2026 +2) RT-114 data: more Phase 1a data by end of 2026, and a Phase 1b repeat-dose study in patients with obesity starting by end of 2026, with results in 2027. (rttnews) Chugai milestone payments: about $18M in technology-transfer milestones expected, plus up to $57M in development milestones. (itiger) (sec) Leadership Mir Imran: founder, Executive Chairman Talat Imran: CEO since June 2021, with the executive team since 2014 (ranitherapeutics) Nicholas Maestas: CFO , hired June 2026 Mir Hashim, PhD: Chief Scientific Officer Alireza Javadi, PhD: Chief Tech O
3
paolo73
$RANI Apologies, I haven’t had time to read the latest news due to my father’s health issues. If I’ve understood correctly, the company has stated that it intends to move its Class A shares to the Nasdaq Capital Market in order to gain an additional 180 days—is that right? Thanks, everyone.
2
Paipas2003
$RANI entré en rani hace 1 año, sinceramente confiaba y confío mucho a dia de hoy en el proyecto. Con llevarnos una cuota del 1% del mercado de la obesidad rani valdría 20 veces más de lo que vale ahora. Ahora necesitamos socios estratégicos que apuesten por nuestra plataforma y quieran que metamos sus moléculas en la ranipill. Si los datos que den en q1 de 2027 sobre la fase 1b de rt114 son positivos, creo que 2027 será un gran año. empezar la fase 2, tener dinero en caja y apuntar a por nuevos socios. Espero ver a rani de aqui a dos años en 7 u 8 dolares por acción.
1
wavw
$RANI there’s a reason for AI stock to fall which are trading at 50x and above. But why this one is going down.
1
Shannon667
$RANI testing .55 cents tomorrow if it holds might see a bit of a bounce if not .50 cents will be next
Mjust
$RANI As of Sept. 30, Rani reported $3.62M in cash and $41.67M in marketable securities, approximately $45.3M combined. The company also transferred to the Nasdaq Capital Market and has until May 10, 2027, to regain minimum bid-price compliance. The marketable securities provide additional liquidity, depending on their composition and maturity. However, the bigger questions are cash burn, funding requirements for clinical development, and potential dilution if additional capital is needed.
focafoca99
$RANI announced its Q3 and nine-month 2026 results in a press release attached to the 8-K.
wavw
$RANI if someone ready to accumulate for 3-4 million can easily take above 1. The management should have the proxy traders to uplift. I don’t know why they are reluctant to do it.
Giambu
$RANI la scadenza della conformità è il 09 novembre e questi non rilasciano nessun comunicato. INCREDIBILE!!!

Advertisement|Remove ads.